the twice-a-day tablet has carried the fda 's strongest warning label since 2009 .
the twice-a-day tablet has carried the fda 's strongest warning label since 2009 , following reports of suicidal tendencies and violent or bizarre behavior among some patients .
the fda on monday outlined several updates to chantix 's labeling , including a new warning about its potential interaction with alcohol .